Back
Sarepta Therapeutics Stock Predictions
Data Just Made Palantir Worth $200B - Is This #1 Software Company Next?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41
SRPT
Sarepta Therapeutics
Last Price:
$105.09
Seasonality Move:
1.75%
7 Day Trial
ALL ACCESS PASS
$
7
Attention Investors: The 10 Best stocks for 2025 - yours FREE
Get Your Copy of "10 Best Stocks to Own in 2025" Here.Sarepta Therapeutics Stock Forecast
-
Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 49.1% based on the past 27 years of stock performance.
-
Sarepta Therapeutics has risen higher in 12 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
-
Is Sarepta Therapeutics Stock Undervalued?The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Sarepta Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 49.1% based on the past 27 years of stock performance.
Sarepta Therapeutics Stock Rating
Sell
41
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics overpriced?
-
Sarepta Therapeutics has risen higher in 12 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
Sarepta Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sarepta.com
52-Week Data
52-Week High:
173.25
52-Week Low:
102.16
Prediction Charts
Market Cap:
10.3B
Price in USD:
107.95
Volume:
620K
Beta:
1.06
Technical Analysis
SMA50:
119.80
SMA100:
121.08
SMA200:
128.55
52-Wk Change:
-13.15%
Stock Predictions
-
Is Sarepta Therapeutics stock public?Yes, Sarepta Therapeutics is a publicly traded company.
-
What is the Sarepta Therapeutics stock quote today?The Sarepta Therapeutics stock price is 107.95 USD today.
-
How to buy Sarepta Therapeutics stock online?You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-28 | 117.12 | 117.51 | 118.28 | 116.54 |
| Jan-29 | 117.24 | 115.45 | 117.50 | 113.38 |
| Jan-30 | 115.53 | 114.45 | 116.24 | 113.46 |
| Jan-31 | 114.87 | 113.72 | 116.15 | 112.78 |
| Feb-3 | 111.48 | 113.81 | 114.80 | 111.48 |
| Feb-4 | 113.14 | 114.08 | 115.12 | 112.87 |
| Feb-5 | 114.71 | 119.02 | 120.05 | 114.46 |
| Feb-6 | 118.78 | 112.11 | 119.27 | 112.06 |
| Feb-7 | 112.00 | 111.82 | 112.37 | 109.52 |
| Feb-10 | 112.00 | 112.74 | 114.41 | 110.81 |
| Feb-11 | 110.52 | 109.68 | 111.59 | 109.55 |
| Feb-12 | 109.00 | 109.81 | 110.34 | 108.17 |
| Feb-13 | 109.40 | 109.46 | 110.11 | 107.74 |
| Feb-14 | 109.84 | 107.95 | 111.21 | 107.61 |
Sarepta Therapeutics Earnings
Sarepta Therapeutics Earnings Report: Per Share Sarepta Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Sarepta Therapeutics Forecast Revenue Growth
Sarepta Therapeutics Stock Analysis: Historical quarterly revenues per share for Sarepta Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.